23 Results for "

aldose reductase (ALR2)

" in MedChemExpress (MCE) Product Catalog:
Products (23)

23 Results for "aldose reductase (ALR2)" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-106697
CAS No.: 72702-95-5
Purity:  99.51%
Synonyms: ICI 128436
Target:  

Aldose Reductase

Research Areas:  

Metabolic Disease

Ponalrestat (ICI 128436) is an orally active, selective and noncompetitive aldose reductase (AKR1B1; ALR) inhibitor. Ponalrestat selectively inhibits ALR2 (Ki=7.7 nM) over ALR1 (Ki=60 μM). Ponalrestat inhibits the conversion of glucose to sorbitol .
loading...
    loading...
Cat. No.: HY-175331
CAS No.: 59935-47-6
Target:  

Aldose Reductase

Research Areas:  

Metabolic Disease Cancer

ALR2-IN-7 (Compound 5a) is a highly potent and selective aldose reductase (ALR2/AKR1B1) inhibitor (Ki=8.71 nM). ALR2-IN-7 is promising for research of diabetic complications (e.g., retinopathy, nephropathy) and cancers .
loading...
    loading...
Cat. No.: HY-121933
CAS No.: 314297-26-2
Target:  

Aldose Reductase

Research Areas:  

Metabolic Disease

IDD388 is a selective aldose reductase (ALR2) inhibitor with an IC50 of 30 nM. IDD388 displays selectivity for ALR2 over ALR1 (IC50 of 14 μM) .
loading...
    loading...
Cat. No.: HY-147977
CAS No.: 2419233-57-9
Target:  

Aldose Reductase

Research Areas:  

Cancer

ALR1/2-IN-1 (Compound 6e) is an aldehyde reductase (ALR1) and aldose reductase (ALR2) inhibitor with IC50 values of 3.26 μM and 3.06 μM against ALR1 and ALR2, respectively. ALR1/2-IN-1 shows anticancer activity .
loading...
    loading...
Cat. No.: HY-N12313
CAS No.: 518-77-4
Corybulbine, an alkaloid that can be isolated from the methanolic extract of Corydalis ternata, is an aldose reductase (ALR2) inhibitor. Corybulbine can be used for diabetic complications research .
loading...
    loading...
Cat. No.: HY-W011786
CAS No.: 84946-20-3
Target:  

Aldose Reductase

Research Areas:  

Metabolic Disease

2-Chloro-1-(4-fluorobenzyl)-1H-benzo[d]imidazole is an inhibitor of larval settlement in marine organisms, demonstrating low toxicity while effectively inhibiting the metamorphosis of species such as barnacles, bryozoans, and polychaetes. 2-Chloro-1-(4-fluorobenzyl)-1H-benzo[d]imidazole also exhibits activity as an aldose reductase (ALR2) inhibitor, indicating potential therapeutic applications in diabetes-related complications.
loading...
    loading...
Cat. No.: HY-151946
Target:  

Aldose Reductase

Research Areas:  

Metabolic Disease

ALR2-IN-2 is a potent inhibitor of aldose reductase (ALR2), with IC50s of 27 nM and 228 nM for rat ALR2 and ALR1, respectively. ALR2-IN-2 can be used for the research of diabetic complications .
loading...
    loading...
Cat. No.: HY-151947
CAS No.: 3062622-02-7
Target:  

Aldose Reductase

Research Areas:  

Metabolic Disease

ALR2-IN-2 is a potent inhibitor of aldose reductase (ALR2), with IC50s of 22 nM and 116 nM for rat ALR2 and ALR1, respectively. ALR2-IN-2 can be used for the research of diabetic complications .
loading...
    loading...
Cat. No.: HY-175639
ALR2-IN-8 is a potent aldose reductase (ALR2/AKR1B1) inhibitor with a KI of 7.34 nM. ALR2-IN-8 has extremely low toxicity to normal cells and has a weak direct killing effect on cancer cells. ALR2-IN-8 can used for the studies of diabetic and inflammation-linked disorders .
loading...
    loading...
Cat. No.: HY-175854
Target:  

Aldose Reductase

Research Areas:  

Cancer

Aldose reductase-IN-9 (Compound 8b) is an Aldose reductase (ALR2) inhibitor with a Ki value of 3.59 nM. Aldose reductase-IN-9 has anti-tumor activity .
loading...
    loading...
Cat. No.: HY-146129
CAS No.: 2480090-03-5
Target:  

Aldose Reductase

Research Areas:  

Metabolic Disease

As an aldose reductase (ALR2) inhibitor, the compound is used to enhance the combination of inhibitory excitability and antioxidant capacity to delay the progress of diabetes complications.
loading...
    loading...
Cat. No.: HY-146661
CAS No.: 2446136-17-8
Target:  

Aldose Reductase

Research Areas:  

Cancer

Aldose reductase-IN-4 (compund IIc) is an aldose reductase inhibitor with IC50s of 11.70 μM and 0.98 μM for aldehyde reductase 1 (ALR1) and ALR2, respectively .
loading...
    loading...
Cat. No.: HY-W151897
CAS No.: 309283-89-4
Synonyms: CMTI
Target:  

Aldose Reductase

Research Areas:  

Metabolic Disease

Cemtirestat (CMTI) is a carboxymethylated thiatriazinoindole inhibitor of aldose reductase (ALR2). Cemtirestat potently inhibits rat ocular lens ALR2 with an IC50 of 0.116 μM, and exhibits a 302-fold selectivity for rat kidney ALR1. Cemtirestat is applicable to the research of advanced diabetic complications .
loading...
    loading...
Cat. No.: HY-184283
ALR2-IN-11 is a competitive aldose reductase (ALR2) inhibitor with a Ki value of 0.052 μM. ALR2-IN-11 can be used for the research of diabetic complications .
loading...
    loading...
Cat. No.: HY-W283860
CAS No.: 135-64-8
Target:  

Aldose Reductase

Research Areas:  

Metabolic Disease

ALR2-IN-10 (Compound 23) is a weak Aldose Reductase 2 inhibitor with inhibition rate of 6% at 27 μM. ALR2-IN-10 can be used for the research of diabetic complication .
loading...
    loading...
Cat. No.: HY-184330
Research Areas:  

Metabolic Disease

ALR2/α-Glucosidase-IN-2 is an inhibitor of α-glucosidase and aldose reductase ALR2. ALR2/α-Glucosidase-IN-2 has a Ki value of 11.68 nM against yeast α-glucosidase and a Ki value of 72.64 nM against ovine ALR2. ALR2/α-Glucosidase-IN-2 inhibits intestinal carbohydrate digestion regulatory enzymes and key enzymes in the polyol pathway. ALR2/α-Glucosidase-IN-2 can be used in diabetes-related research .
loading...
    loading...
Cat. No.: HY-P81338
Synonyms: AR; ADR; ALR2; ALDR1

Host:  

Mouse

Application:  

WB

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
Cat. No.: HY-P81338A
Synonyms: AR; ADR; ALR2; ALDR1

Host:  

Mouse

Application:  

WB

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
Cat. No.: HY-187119
CAS No.: 158575-73-6
Target:  

Aldose Reductase

Research Areas:  

Metabolic Disease

CC13401 is an aldose reductase (ALR2) inhibitor with an IC50 of 41.41 μM in rats. CC13401 inhibits the NADPH-dependent reduction reaction catalyzed by ALR2. CC13401 can be used in studies on the mechanisms related to the polyol pathway and diabetic complications .
loading...
    loading...
Cat. No.: HY-181519
ALR2/α-GLY-IN-1 is a potent dual-target inhibitor that targets aldose reductase ALR2 and α-glucosidase (IC50 values are 0.72 μM and 0.82 μM, respectively; Ki values are 1.67 μM and 1.37 μM, respectively). ALR2/α-GLY-IN-1 also acts as a DNA binder, which stably interacts with calf thymus double-stranded DNA through non-covalent interactions such as groove-binding mode and water-bridged hydrogen bonds. ALR2/α-GLY-IN-1 can be used in studies related to diabetes and its complications .
loading...
    loading...